Wegovy is the FDA-approved weight loss formulation of semaglutide, dosed at higher levels than Ozempic. Clinical trials showed an average of 15% body weight loss over 68 weeks. We provide the full prescribing, titration, and monitoring cycle through telehealth.
Signs & symptoms
- BMI ≥ 30 (obesity)
- BMI ≥ 27 with at least one weight-related condition
- Desire for an FDA-approved weight loss medication (not off-label)
- Previous success with lower-dose semaglutide seeking higher efficacy
- Insurance requires FDA-approved indication for coverage
- Preference for weekly injection over daily medication
Our approach
Wegovy follows a structured 16-week dose escalation schedule. We guide you through each step, monitoring for GI side effects, ensuring adequate nutrition, and adjusting if needed. Regular follow-ups keep you on track and safe throughout the program.
Who is this for?
Adults who qualify for prescription weight loss medication and prefer an FDA-approved, well-studied option with a clear titration schedule.
Start your journey to total wellness today.
No referral needed. Most major insurance plans accepted. Telehealth appointments available across DC and Maryland.